ovarian-cancer

Documents about ovarian-cancer

• A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.#373613ClinicalTrials.gov
• A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors#858509ClinicalTrials.gov
• A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery#903753ClinicalTrials.gov
• The role of circadian disruption, sleep dysregulation, lifestyle factors, and metabolic reprogramming in the pathogenesis and progression of ovarian cancer.#25870NCBI PubMed Central
• Endocrine therapy in advanced high-grade ovarian cancer: real-life data from a multicenter study and a review of the literature#168473HAL (France)
• Real-world activity of trastuzumab deruxtecan in heavily pretreated HER2-expressing ovarian cancer: focusing on HER2-low responses and CCNE1 amplification#410918bioRxiv / medRxiv
• Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer#677079HAL (France)
• Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer#784098Deutsche Nationalbibliothek
• Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies#804497ClinicalTrials.gov
• Pediatric Reporting of Adult-Onset Genomic Results#860799ClinicalTrials.gov
• A Study of NX-1607 in Adults With Advanced Malignancies#879199ClinicalTrials.gov
• Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors#839349ClinicalTrials.gov
• A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors#252982ClinicalTrials.gov
• Genetically predicted inflammatory cytokines mediate the associations between the gut microbiota and ovarian cancer: a bidirectional two-sample Mendelian randomization study.#9075NCBI PubMed Central
• Self-collected biospecimen consent and return rates in a population-based study among women with ovarian cancer: insights from the ORCHiD study.#136029NCBI PubMed Central
• PARP16 is a Druggable Regulator of Ribosome MARylation and Protein Homeostasis in Ovarian Cancer Cells#152097Unpaywall
• Replication Data for: The ADNEX risk model for ovarian cancer diagnosis: A systematic review and meta-analysis of external validation studies#218559KU Leuven RDR Dataverse OAI Archive
• A Novel Approach to Ovarian Cancer Diagnosis via CT Imaging: GPT-4o-Driven Automated Feature Recognition and Validation in Clinical Settings.#269480NCBI PubMed Central
• Context-dependent roles of HtrA2/Omi in ovarian cancer: mitochondrial apoptotic function linking platinum sensitivity and acquired chemoresistance-a narrative review.#685604NCBI PubMed Central
• Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201#922890HAL (France)
• Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery#899192ClinicalTrials.gov
• Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer#905340ClinicalTrials.gov
• Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors#856614ClinicalTrials.gov
• Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial#896257ClinicalTrials.gov
• Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI#846956ClinicalTrials.gov
• A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors#804465ClinicalTrials.gov
• Endothelin-1 drives invadopodia and interaction with mesothelial cells through ILK#247052IRIS
• A Multi-Omics and Single-Cell Framework Identifies ITGA1 as a Candidate Predictive Biomarker of Neoadjuvant Chemotherapy Response in Epithelial Ovarian Cancer.#375278NCBI PubMed Central
• Impact of prehabilitation on quality of life and mental health in patients awaiting cytoreductive surgery for ovarian cancer or suspected adnexal tumors.#388586NCBI PubMed Central
• Single-cell and spatial profiling reveal an IL-10-associated iCAF-M2 macrophage communication axis in high-grade serous ovarian cancer ascites.#402689NCBI PubMed Central
• Health care access domains and treatment as mediators of ovarian cancer racial disparities in survival: a structural equation modeling analysis in SEER-Medicare.#430952NCBI PubMed Central
• Clinical Outcomes for Offering Genetic Testing in a Tiered Approach#801837ClinicalTrials.gov
• Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma#874670ClinicalTrials.gov
• Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors#876209ClinicalTrials.gov
• The impact of mental health conditions on attitudes towards help-seeking and diagnostic testing for potential ovarian cancer symptoms: An online vignette study#4892Europe PMC
• Prediction Model for Overall Survival in Patients with Epithelial Ovarian Cancer Undergoing Surgery and Systemic Therapy Based on the 2010–2021 SEER Database.#151447NCBI PubMed Central
• Optimizing ovarian dose sparing for young cervical cancer patients after oophoropexy: a dosimetric and radiobiological comparison of three radiotherapy techniques (IMPT, TOMO, and VMAT).#446157NCBI PubMed Central
• Combination Chemotherapy in Treating Patients With Sarcoma#849587ClinicalTrials.gov
• Actionable Biomarker Co-Expression in Advanced Ovarian Cancer: Folate Receptor alpha Expression and Related Markers#676036eScholarship
• Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25#833642ClinicalTrials.gov
• Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology Surgery#839984ClinicalTrials.gov
• Evaluation of the TiaoShenZhiAi Regimen for Patients With Ovarian Cancer Experiencing a Psychoneurological Symptom Cluster: Protocol for a Multicenter, Double-Blind, Randomized Controlled Trial.#284849NCBI PubMed Central
• Estrogen biosynthesis and signal transduction in ovarian disease#443644Spiral
• Microarray Analysis for Human Genetic Disease#837726ClinicalTrials.gov
• A Phase I Dose-finding Trial of Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin#870765ClinicalTrials.gov
• Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3#780454eScholarship
• Context-Dependent Reconfiguration And Spatial Reorganisation Of The Mir-199A-5P/Xiap Axis In High-Grade Serous Ovarian Cancer#164903Unpaywall
• Primary Cytoreductive Surgery Versus Neoadjuvant Chemotherapy Followed by Surgery in Patients with Advanced Primary Epithelial Ovarian Cancer in Low Resources Setting: A Randomized Clinical Trial.#247609NCBI PubMed Central
• Strengthening the shield: Cognitive behavioral therapy as a critical adjunct in ovarian cancer chemotherapy - Evidence from a systematic review and meta-analysis of randomized controlled trials.#371317NCBI PubMed Central
• Perioperative Assessment of Right Ventricular Function and Venous Return in Patients With Epithelial Ovarian Cancer Undergoing Cytoreductive Surgery (Gyn Right) - Pilot Study#405237ClinicalTrials.gov